Patient Square Capital LP
CIK 1819257 · View on SEC EDGAR ↗
- Portfolio value
- $645.5M
- Positions
- 23
- As of
- June 30, 2026
#3,225 of 9,443 by 13F value · top 34.2%
Portfolio value QoQ: +14.5% 13F does not disclose cash
- Top 10 holdings weight
- 80.13%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 21
- Effective number of positions
- 4.7
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 23.37% Est. buys $141,268,557 · sells $146,232,574
Median holding: 2.5 quarters Tracked Q4 2024–Q2 2026 · 41.1% still held
- New positions
- 6
- Increased
- 9
- Decreased
- 8
- Closed
- 12
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +80.5% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 98.9% · Options excluded: 0.0%
Sector breakdown
Healthcare
100.0%
Full portfolio 23 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. - Common Shares | $283,860,642 | 43.97% | 8,020,928 | $57,661,140 | Down ×1 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $51,689,280 | 8.01% | 276,000 | Up ×1 | |||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $30,496,735 | 4.72% | 260,500 | $9,249,335 | Up ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $27,518,190 | 4.26% | 206,500 | $14,017,559 | Up ×1 | ||
| ONC BeOne Medicines Ltd. - American Depositary Shares | $25,652,999 | 3.97% | 90,020 | $1,734,441 | Up ×2 | ||
| PHVS Pharvaris N.V. - Ordinary Shares | $23,210,407 | 3.60% | 671,209 | $9,283,157 | Up ×1 | ||
| ARGX argenx SE - American Depositary Shares | $21,338,710 | 3.31% | 23,000 | $-5,474,610 | Down ×1 | ||
| UTHR United Therapeutics Corporation - Common Stock | $20,112,730 | 3.12% | 37,120 | Up ×1 | |||
| BLTE Belite Bio, Inc - American Depositary Shares | $16,938,350 | 2.62% | 110,000 | $-1,665,747 | Down ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $16,447,500 | 2.55% | 425,000 | $-6,492,540 | Down ×1 | ||
| DBVT DBV Technologies S.A. - American Depositary Shares | $14,915,374 | 2.31% | 909,474 | $427,449 | Up ×2 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $13,279,200 | 2.06% | 220,000 | $79,150 | Down ×1 | ||
| BNTX BioNTech SE - American Depositary Shares | $12,508,618 | 1.94% | 134,429 | Up ×1 | |||
| RCUS Arcus Biosciences, Inc. Common Stock | $10,969,314 | 1.70% | 355,800 | $6,757,314 | Up ×2 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $10,784,375 | 1.67% | 212,500 | $2,944,375 | Up ×1 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $10,527,840 | 1.63% | 108,000 | $2,649,263 | Up ×1 | ||
| ALLO Allogene Therapeutics, Inc. - Common Stock | $10,504,000 | 1.63% | 5,050,000 | $2,086,000 | Up ×1 | ||
| EYPT EyePoint, Inc. - Common Stock | $10,296,000 | 1.59% | 720,000 | $48,450 | Down ×1 | ||
| ARQT Arcutis Biotherapeutics, Inc. - Common stock | $9,701,400 | 1.50% | 370,000 | $262,204 | Down ×1 | ||
| CCCC C4 Therapeutics, Inc. - Common Stock | $7,513,166 | 1.16% | 1,608,815 | Up ×1 | |||
| IVA Inventiva S.A. - American Depository Shares | $7,435,906 | 1.15% | 1,967,171 | Up ×1 | |||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $5,446,825 | 0.84% | 47,500 | $-2,882,175 | Down ×2 | ||
| SNSE Sensei Biotherapeutics, Inc. - Common Stock | $4,376,250 | 0.68% | 175,050 | Up ×1 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| ROIV | Trimmed | -145K | +$57.7M |
| ABVX | Bought more | +85K | +$14.0M |
| PHVS | Bought more | +178K | +$9.3M |
| MIRM | Bought more | +30K | +$9.2M |
| RCUS | Bought more | +161K | +$6.8M |
| COGT | Trimmed | -171K | -$6.5M |
| ARGX | Trimmed | -14K | -$5.5M |
| ELVN | Bought more | +12K | +$2.9M |
| KYMR | Trimmed | -52K | -$2.9M |
| DNTH | Bought more | +14K | +$2.6M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| INSM | June 30, 2026 | 157,500 | $25,754,400 | 20.4% |
| LEGN | June 30, 2026 | 990,000 | $17,909,100 | -22.4% |
| NKTR | June 30, 2026 | 210,000 | $15,109,500 | 7.2% |
| TERN | March 31, 2026 | 320,000 | $12,928,000 | No longer tracked |
| CDTX | Dec. 31, 2025 | 121,000 | $11,586,960 | No longer tracked |
| CELC | June 30, 2026 | 95,000 | $10,843,300 | -12.1% |
| MRK | June 30, 2026 | 80,000 | $9,623,200 | 17.0% |
| LQDA | March 31, 2026 | 227,000 | $7,829,230 | 93.2% |
| CATX | June 30, 2026 | 1,625,000 | $6,776,250 | No longer tracked |
| CGEM | Sept. 30, 2025 | 868,897 | $6,542,794 | 267.0% |
| DFTX | June 30, 2026 | 331,000 | $6,255,900 | -5.3% |
| ITCI | March 31, 2025 | 71,990 | $6,012,605 | No longer tracked |
| OCUL | March 31, 2026 | 490,000 | $5,948,600 | 35.2% |
| IRON | March 31, 2026 | 74,000 | $5,876,340 | 24.1% |
| HROW | June 30, 2026 | 165,209 | $5,825,269 | -0.8% |
| AVTX | March 31, 2026 | 311,966 | $5,665,303 | 35.8% |
| SRRK | Sept. 30, 2025 | 154,000 | $5,454,680 | 48.8% |
| AGIO | Dec. 31, 2025 | 133,827 | $5,371,816 | 25.3% |
| TARA | June 30, 2026 | 1,030,846 | $5,370,708 | 2.4% |
| CTMX | June 30, 2026 | 1,085,790 | $5,103,213 | -6.7% |
| GERN | March 31, 2025 | 1,321,268 | $4,677,289 | -1.6% |
| QURE | Dec. 31, 2025 | 75,000 | $4,377,750 | 100.2% |
| AMLX | March 31, 2026 | 350,000 | $4,228,000 | 177.1% |
| NRIX | Dec. 31, 2025 | 437,237 | $4,040,070 | 42.2% |
| ASMB | June 30, 2026 | 136,315 | $3,782,741 | 21.3% |
| BPMC | June 30, 2025 | 38,500 | $3,407,635 | No longer tracked |
| SWTX | March 31, 2025 | 93,137 | $3,365,040 | No longer tracked |
| ARVN | March 31, 2025 | 86,627 | $1,660,640 | 34.9% |
| NTLA | June 30, 2025 | 232,781 | $1,655,073 | 35.1% |
| SLNO | June 30, 2025 | 18,600 | $1,328,970 | No longer tracked |
| GERN | Dec. 31, 2025 | 845,000 | $1,157,650 | 18.6% |
| ATXS | March 31, 2025 | 105,057 | $939,210 | No longer tracked |
| VYNE | Sept. 30, 2025 | 317,033 | $523,104 | No longer tracked |
| SYRE | June 30, 2026 | 1,000 | $50,440 | 19.3% |